NSEGeneral Updates3d ago · 3 Sept 2026, 12:20 pm
General Updates
Shukra Pharmaceuticals Limited · SHUKRAPHAR
✦ AI SummaryDividend
Shukra Pharmaceuticals Limited has informed the Exchange about General Updates, specifically the Record Date for determining eligibility for Final Dividend for the financial year ended 31 March, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shukra Pharmaceuticals Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
SHUKRA_03092026122008_Shukra_Record_Date_Dividend_Intimation.pdf
View document text
September 03, 2026
The Department of Corporate Services Listing Department
BSE Limited National Stock Exchange of India Limited
Ground Floor, P. J. Tower, Exchange Plaza, 5 Floor Plot No. C/1,
Dalal Street, G. Block Bandra-Kurla Complex,
Mumbai-400001 Bandra (E), Mumbai - 400 051
Scrip Code: 524632
NSE Symbol: SHUKRAPHAR
Sub: Intimation of Record Date for determining eligibility for Final Dividend pursuant to
Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015
Dear Sir/Madam,
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform you that the Company has
fixed Monday, September 21, 2026 as the Record Date for determining the eligibility of
members entitled to receive the Final Dividend of % 0.01/- per equity share of face value of
X 1/- each for the financial year ended 31 March, 2026, subject to declaration of the said
Final Dividend by the members of the Company at the ensuing 33 Annual General
Meeting (“AGM”).
The details are as follows:
Security Code | Type of Record Date | Purpose Final Annual
/ Symbol Security Dividend General
proposed Meeting
524632/ Equity Share | Monday, 21" | Determining | X 0.01/- per | 33 AGM to
SHUKRAPHAR September, | the eligibility | equity share | be held on
2026 of members | of face value | Monday,
entited to | of X 1/- each | September
receive Final 28,2026
Dividend for
FY 2025-26
The Final Dividend is subject to approval of the members at the ensuing AGM. Upon
declaration of the Final Dividend, the same shall be paid to those members whose names
appear in the Register of Members of the Company or in the records of the Depositories, as
applicable, as on the aforesaid Record Date.
CIN : L24231GJ1993PLC019079
Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317
Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com
The Final Dividend, if declared at the AGM, shall be paid within ays from the date of
declaration, in accordance with the applicable provisions of the Companies Act, 2013,
In accordance with Regulation 42 of the SEBI LODR Regulations, the Record Date has been
fixed after giving the requisite advance notice to the Stock Exchange(s).
The above information is being furnished for your information and record.
Thanking you,
Yours faithfully,
For Shukra Pharmaceuticals Limited,
Name: Shivkant Dhakad
Designation: Company Secretary-cum-Compliance Officer
Membership No.: A80894
CIN : L24231GJ1993PLC019079
Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, I_ndia, Ph. :02764-286317
Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com